“PLA2R-positive membranous nephropathy treated with rituximab (MENTOR regimen) in a patient with concomitant endometrial carcinoma: A case report”., REV SEN, vol. 14, no. 3S, pp. 57–58, Jul. 2026, doi: 10.56867/.